The reimbursement experience physicians are having with AbbVie’s (NYSE:ABBV) Orilissa (elagolix) in endometriosis-related pain is likely...

Dr. Joanne Liu, you have served as International President of Médecins Sans Frontières (MSF) since 2013 and have been involved with the...

FROM THE PUBLISHER Welcome to the inaugural edition of the World Asian Medical Journal (WAMJ)! I am immensely delighted that WAMJ has...

Dr. Kim, you are a successful ophthalmologist and a respected member of the medical community. What motivated you to specialize in...

October 2016 - December 2016 Trump Proposes to Lower Drug Prices by Basing Them on Other Countries’ Costs In a speech at the U.S....

North America 37th Annual J.P. Morgan Healthcare Conference January 7-10, 2019 |  San Francisco, California, USA Website:...

Aclaris Therapeutics’ (NASDAQ:ACRS) Phase II ATI-502 for alopecia areata (AA) and Phase II for ATI-501 for AA, alopecia universalis (AU)...

Aldeyra Therapeutics’ (NASDAQ:ALDX) focus on seasonal allergies in its Phase III study of reproxalap in allergic conjunctivitis has three...

FROM THE PUBLISHER Our 18th issue marks the end of 2018, a year full of changes, challenges and controversies regarding healthcare,...

With the 11th New York Health Forum (NYHF) coming December at the Yale Club of New York, with the theme “Healthcare and Life Sciences...